Sort   by:  
 Page size 
UnknownFully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate.
Not available
S-EPMC6249570 | biostudies-literature
UnknownIdentifying candidate Aspergillus pathogenicity factors by annotation frequency.
Not available
S-EPMC7661267 | biostudies-literature
UnknownThe cumulative prevalence of HIV-1 drug resistance in perinatal HIV.
Not available
S-EPMC12237116 | biostudies-literature
UnknownThe genetics of circulating BDNF: towards understanding the role of BDNF in brain structure and function in middle and old ages.
Not available
S-EPMC7734441 | biostudies-literature
UnknownImmunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11272042 | biostudies-literature
UnknownNovavax NVX-COV2373 triggers neutralization of Omicron sub-lineages.
Not available
S-EPMC9867547 | biostudies-literature
UnknownTau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease.
Not available
S-EPMC6240334 | biostudies-literature
UnknownEfficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
Not available
S-EPMC8091623 | biostudies-literature
UnknownA second X chromosome contributes to resilience in a mouse model of Alzheimer's disease.
Not available
S-EPMC8409261 | biostudies-literature
UnknownImmunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-MTM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial.
Not available
S-EPMC11789733 | biostudies-literature
Sort   by:  
 Page size